Nutrient sensing and insulin signaling in neuropeptide-expressing immortalized, hypothalamic neurons: A cellular model of insulin resistance

Cell Cycle

Volumn 9, Issue 16, 2010, Pages 3206-3213

  Fick, Laura J ^a   Belsham, Denise D ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Glucose signaling; Hypothalamus; Insulin resistance; Insulin signaling; Neuropeptides; Palmitate

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; CYCLIC AMP; GLUCAGON LIKE PEPTIDE; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INSULIN; INSULIN RECEPTOR; JANUS KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; NEUROPEPTIDE; PALMITIC ACID; SATURATED FATTY ACID; SUPPRESSOR OF CYTOKINE SIGNALING;

AUTOPHOSPHORYLATION; B LYMPHOCYTE; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; INSULIN BINDING; INSULIN RESISTANCE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUTRIENT; OBESITY; PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW;

EID: 77955764182     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.16.12601     Document Type: Review

References (52)

1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444:840-6.
2. Haslam DW, James WP. Obesity. Lancet 2005; 366:1197-209.
3. Nishida C, Uauy R, Kumanyika S, Shetty P. The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: Process, product and policy implications. Public Health Nutr 2004; 7:245-50.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-53.
5. Everitt BJ, Hokfelt T. Neuroendocrine anatomy of the hypothalamus. Acta Neurochir Suppl (Wien) 1990; 47:1-15.
6. Gao Q, Horvath TL. Neuronal control of energy homeostasis. FEBS Lett 2008; 582:132-41.
7. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006; 443:289-95.
8. Wilding JP. Neuropeptides and appetite control. Diabet Med 2002; 19:619-27.
9. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D. Transgenic rescue of insulin receptor-deficient mice. J Clin Invest 2004; 114:214-23.
10. Okamoto H, Obici S, Accili D, Rossetti L. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 2005; 115:1314-22.
11. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 289:2122-5.
12. Belsham DD, Cai F, Cui H, Smukler SR, Salapatek AM, Shkreta L. Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders. Endocrinology 2004; 145:393-400.
13. van Houten M, Posner BI, Kopriwa BM, Brawer JR. Insulin binding sites localized to nerve terminals in rat median eminence and arcuate nucleus. Science 1980; 207:1081-3.
14. Schwartz MW, Marks JL, Sipols AJ, Baskin DG, Woods SC, Kahn SE, et al. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 1991; 128:2645-7.
15. Wang J, Leibowitz KL. Central insulin inhibits hypothalamic galanin and neuropeptide Y gene expression and peptide release in intact rats. Brain Res 1997; 777:231-6.
16. Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, Clegg DJ, et al. The catabolic action of insulin in the brain is mediated by melanocortins. J Neurosci 2002; 22:9048-52.
17. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev 1995; 16:117-42.
18. Cui H, Cai F, Belsham DD. Anorexigenic hormones leptin, insulin and alpha-melanocyte-stimulating hormone directly induce neurotensin (NT) gene expression in novel NT-expressing cell models. J Neurosci 2005; 25:9497-506.
19. Mayer CM, Belsham DD. Insulin directly regulates NPY and AgRP gene expression via the MAPK MEK/ERK signal transduction pathway in mHypoE-46 hypothalamic neurons. Mol Cell Endocrinol 2009; 307:99-108.
20. Fick LJ, Cai F, Belsham DD. Hypothalamic preproghrelin gene expression is repressed by insulin via both PI3-K/Akt and ERK1/2 MAPK pathways in immortalized, hypothalamic neurons. Neuroendocrinology 2009; 89:267-75.
21. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 1996; 8:205-15.
22. Efrat S, Tal M, Lodish HF. The pancreatic beta-cell glucose sensor. Trends Biochem Sci 1994; 19:535-8.
23. Efrat S. Making sense of glucose sensing. Nat Genet 1997; 17:249-50.
24. Akabayashi A, Zaia CT, Silva I, Chae HJ, Leibowitz SF. Neuropeptide Y in the arcuate nucleus is modulated by alterations in glucose utilization. Brain Res 1993; 621:343-8.
25. Sindelar DK, Ste Marie L, Miura GI, Palmiter RD, McMinn JE, Morton GJ, et al. Neuropeptide Y is required for hyperphagic feeding in response to neuroglucopenia. Endocrinology 2004; 145:3363-8.
26. Cai F, Gyulkhandanyan AV, Wheeler MB, Belsham DD. Glucose regulates AMP-activated protein kinase activity and gene expression in clonal, hypothalamic neurons expressing proopiomelanocortin: Additive effects of leptin or insulin. J Endocrinol 2007; 192:605-14.
27. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY, et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007; 449:228-32.
28. Birch NP, Christie DL, Renwick AG. Immunoreactive insulin from mouse brain cells in culture and whole rat brain. Biochem J 1984; 218:19-27. (Pubitemid 14190917)
29. Havrankova J, Schmechel D, Roth J, Brownstein M. Identification of insulin in rat brain. Proc Natl Acad Sci USA 1978; 75:5737-41.
30. Ristow M, Mulder H, Pomplun D, Schulz TJ, Muller-Schmehl K, Krause A, et al. Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. J Clin Invest 2003; 112:527-34.
31. Gannon M, Shiota C, Postic C, Wright CV, Magnuson M. Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis 2000; 26:139-42. (Pubitemid 30158100)
32. Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Y, White MF. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 2004; 114:908-16. (Pubitemid 39578718)
33. Devaskar SU, Singh BS, Carnaghi LR, Rajakumar PA, Giddings SJ. Insulin II gene expression in rat central nervous system. Regul Pept 1993; 48:55-63. (Pubitemid 23309805)
34. Devaskar SU, Giddings SJ, Rajakumar PA, Carnaghi LR, Menon RK, Zahm DS. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 1994; 269:8445-54.
35. Singh BS, Rajakumar PA, Eves EM, Rosner MR, Wainer BH, Devaskar SU. Insulin gene expression in immortalized rat hippocampal and pheochromocytoma- 12 cell lines. Regul Pept 1997; 69:7-14. (Pubitemid 27219692)
36. Gerozissis K. Brain insulin, energy and glucose homeostasis: Genes, environment and metabolic pathologies. Eur J Pharmacol 2008; 585:38-49.
37. Fridell YW, Hoh M, Kreneisz O, Hosier S, Chang C, Scantling D, et al. Increased uncoupling protein (UCP) activity in Drosophila insulin-producing neurons attenuates insulin signaling and extends lifespan. Aging (Albany NY) 2009; 1:699-713.
38. Schechter R, Beju D, Gaffney T, Schaefer F, Whetsell L. Preproinsulin I and II mRNAs and insulin electron microscopic immunoreaction are present within the rat fetal nervous system. Brain Res 1996; 736:16-27. (Pubitemid 26356458)
39. Madadi G, Dalvi PS, Belsham DD. Regulation of brain insulin mRNA by glucose and glucagon-like peptide 1. Biochem Biophys Res Commun 2008; 376:694-9.
40. Buteau J. GLP-1 receptor signaling: effects on pancreatic beta-cell proliferation and survival. Diabetes Metab 2008; 34:73-7.
41. Cui H, Cai F, Belsham DD. Leptin signaling in neurotensin neurons involves STAT, MAP kinases ERK1/2 and p38 through c-Fos and ATF1. Faseb J 2006; 20:2654-6.
42. Ye J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr Metab Immune Disord Drug Targets 2007; 7:65-74. (Pubitemid 46380417)
43. Chavey C, Fajas L. CXCL5 drives obesity to diabetes and further. Aging (Albany NY) 2009; 1:674-7.
44. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106:171-6.
45. Ozawa K, Miyazaki M, Matsuhisa M, Takano K, Nakatani Y, Hatazaki M, et al. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 2005; 54:657-63.
46. Nakatani Y, Kaneto H, Kawamori D, Yoshiuchi K, Hatazaki M, Matsuoka TA, et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem 2005; 280:847-51.
47. Benoit SC, Kemp CJ, Elias CF, Abplanalp W, Herman JP, Migrenne S, et al. Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. J Clin Invest 2009; 119:2577-89.
48. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008; 29:42-61. (Pubitemid 351252746)
49. Fick LJ, Fick GH, Belsham DD. Rhythmic clock and neuropeptide gene expression in hypothalamic mHypoE-44 neurons. Mol Cell Endocrinol 2010; 323:298-306.
50. Mayer CM, Belsham DD. Central insulin signaling is attenuated by long-term insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation and lysosomal insulin receptor degradation. Endocrinology 2010; 151:75-84.
51. Mayer CM, Belsham DD. Palmitate attenuates insulin signaling and induces endoplasmic reticulum stress and apoptosis in hypothalamic neurons: rescue of resistance and apoptosis through adenosine 5′ monophosphate-activated protein kinase activation. Endocrinology 2010; 151:576-85.
52. Belsham DD, Fick LJ, Dalvi PS, Centeno ML, Chalmers JA, Lee PK, et al. Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis, allowing immortalization of adult murine hypothalamic neurons. Faseb J 2010; 23:4256-65.